Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head
Open Access
- 14 July 2011
- journal article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 12 (1) , 160
Abstract
The pathogenesis of osteonecrosis of the femoral head (ONFH) has been implicated in hypofibrinolysis and blood supply interruption. Previous studies have demonstrated that decreased fibrinolytic activity due to elevated plasminogen activator inhibitor-1 (PAI-1) levels correlates with ONFH pathogenesis. The -675 4G/5G single nucleotide polymorphism (SNP rs1799889) in the PAI-1 gene promoter is associated with PAI-1 plasma level. We investigated whether rs1799889 and two other SNPs of the PAI-1 gene (rs2227631, -844 G/A in the promoter; rs11178, +10700 C/T in the 3'UTR) are associated with increased ONFH risk.Keywords
This publication has 34 references indexed in Scilit:
- Polymorphisms in the Annexin gene family and the risk of osteonecrosis of the femoral head in the Korean populationBone, 2009
- Glucocorticoids in osteonecrosis of the femoral head: A new understanding of the mechanisms of actionThe Journal of Steroid Biochemistry and Molecular Biology, 2009
- Significant association of SREBP-2genetic polymorphisms with avascular necrosis in the Korean populationBMC Medical Genetics, 2008
- Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean populationOsteoarthritis and Cartilage, 2008
- Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean populationExperimental & Molecular Medicine, 2008
- Prognostic Value of PAI1 in Invasive Breast Cancer: Evidence That Tumor-Specific Factors Are More Important Than Genetic Variation in Regulating PAI1 ExpressionCancer Epidemiology, Biomarkers & Prevention, 2006
- Factor V Leiden and Prothrombin Gene MutationClinical Orthopaedics and Related Research, 2004
- THE 2003 MARSHALL R. URIST AWARD PAPER: Genetic Background of OsteonecrosisClinical Orthopaedics and Related Research, 2004
- Risk Period for Developing Osteonecrosis of the Femoral Head in Patients on Steroid TreatmentClinical Rheumatology, 2002
- Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991